BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2013
View Archived Issues
Novel plasmid-encoded treatment for patients with type 1 diabetes
Read More
Osthole-derived compound has beneficial effects on learning and memory
Read More
Preliminary data presented for the anti-protofibrillar Abeta MAb SAR-228810
Read More
Noscira presents results from the ARGO trial of tideglusib
Read More
Merck Serono presents new agents for autoimmune and inflammatory disorders
Read More
Pfizer reports novel GHR antagonist antibodies
Read More
Allergan discloses new prostanoid receptor antagonists
Read More
New PI3Kdelta inhibitors synthesized at Novartis
Read More
Chinese group patents new Raf kinase inhibitors for cancer
Read More
BeiGene synthesizes novel signal transduction pathway inhibitors
Read More
Bausch + Lomb acquires option to license dry eye syndrome drug
Read More
Ensemble Therapeutics and Alexion to discover macrocycle candidates for rare disorders
Read More
Santarus completes enrollment in CONTRIBUTE study
Read More
NIH awards phase I SBIR grant to Cureveda
Read More
Venaxis' pivotal trial of APPY1 Test passes first of two futility analyses
Read More
EMA committee recommends orphan drug status for Soliris in rare neurological disease
Read More
Alkermes describes new pain, multiple sclerosis and cancer immunotherapy candidates
Read More
FDA approves Janssen's Simponi Aria for treatment of moderately to severely active RA
Read More
Celgene to discontinue phase III trial in elderly patients with B-cell CLL
Read More
Mesoblast receives funds from Australian government for R&D activities
Read More
Cooperative phase IIb trial of MediciNova's MN-166 begins in patients with progressive MS
Read More
Phase III study of Spinal Restoration's Biostat System for low back pain misses primary endpoint
Read More
EMA grants orphan drug status to OXiGENE's Zybrestat in ovarian cancer
Read More
AstraZeneca expands cardiovascular disease pipeline with acquisition
Read More
Kyowa Hakko Kirin files application in Japan to expand indication for mogamulizumab
Read More